Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Probiotics in luminal gastroenterology: the current state of play|
|Citation:||Internal Medicine Journal, 2012; 42(12):1287-1291|
|J. M. Andrews and M. Tan|
|Abstract:||In recent years, there has been a growing interest in the use of probiotics in various areas of gastrointestinal (GI) health. Probiotics are defined as live microorganisms that provide beneficial health effects on the host when administered in adequate amounts. Various probiotics have been shown to suppress bacterial growth, modulate the immune system and improve intestinal barrier function. However, despite several studies with promising results, most trials are small and many have substantial methodological limitations. However, with better targeting and appropriate randomised controlled trials, this area may soon yield important therapeutic strategies to optimise GI health. Here, we review the current knowledge of probiotics of relevance to luminal GI health.|
|Keywords:||probiotics; luminal gastroenterology; diarrhoea; inflammatory bowel disease; constipation|
|Rights:||© 2012 The Authors|
|Appears in Collections:||Medicine publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.